Karl F Johnson

Title: The Innovations of Karl F Johnson

Introduction

Karl F Johnson is an accomplished inventor based in the United States. He has made significant contributions to the field of glycosyltransferases and endoglycoceramidases. Although he currently holds no patents, his work has the potential to impact various biotechnological applications.

Latest Patents

Johnson's latest patents include "Methods Of Refolding Mammalian Glycosyltransferases." This invention provides methods for refolding glycosyltransferases produced in bacterial cells, enhancing their usability in various applications. Additionally, he has developed "Mutant Endoglycoceramidases With Enhanced Synthetic Activity." This invention focuses on a novel endoglycoceramidase with reduced hydrolytic activity, making it useful for synthesizing glycolipids from monosaccharides or oligosaccharides and ceramides.

Career Highlights

Throughout his career, Johnson has worked with notable organizations such as La Jolla Pharmaceutical Company and the University of British Columbia. His experience in these institutions has allowed him to refine his expertise in biochemistry and enzymatic processes.

Collaborations

Some of his coworkers include Shawn Defrees and Mark Vaughan. Their collaborative efforts have contributed to the advancement of research in their respective fields.

Conclusion

Karl F Johnson's innovative work in glycosyltransferases and endoglycoceramidases showcases his dedication to advancing biotechnological applications. His contributions, although not yet patented, hold promise for future developments in the industry.